Literature DB >> 21175551

Relationship between cytomegalovirus infection and procoagulant changes in human immunodeficiency virus-infected patients.

R Mulder1, Y I G V Tichelaar, H G Sprenger, A B Mulder, W M Lijfering.   

Abstract

Cytomegalovirus is associated with hypercoagulability, and is reported to increase the risk of venous thrombosis in human immunodeficiency virus (HIV)-infected patients. Progression to AIDS, however, is also associated with hypercoagulability and venous thrombosis, and may result in more comorbidities, such as reactivation of cytomegalovirus. It is therefore unknown whether active cytomegalovirus in HIV infection results in a procoagulant state or whether hypercoagulability is the result of HIV infection itself. In this cross-sectional study of 104 consecutive HIV-infected patients, active cytomegalovirus infection was associated with hypercoagulability independently of stage of HIV disease. This finding may deserve attention in preventative recommendations for use of thromboprophylaxis in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21175551     DOI: 10.1111/j.1469-0691.2010.03415.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  7 in total

1.  Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV.

Authors:  Laura W Musselwhite; Virginia Sheikh; Thomas D Norton; Adam Rupert; Brian O Porter; Scott R Penzak; Jeff Skinner; JoAnn M Mican; Colleen Hadigan; Irini Sereti
Journal:  AIDS       Date:  2011-03-27       Impact factor: 4.177

2.  Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women.

Authors:  Christina M Parrinello; Elizabeth Sinclair; Alan L Landay; Nell Lurain; A Richey Sharrett; Stephen J Gange; Xiaonan Xue; Peter W Hunt; Steven G Deeks; Howard N Hodis; Robert C Kaplan
Journal:  J Infect Dis       Date:  2012-04-05       Impact factor: 5.226

3.  HIV-Associated Venous Thromboembolism.

Authors:  Michele Bibas; Gianluigi Biava; Andrea Antinori
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-07-08       Impact factor: 2.576

4.  Understanding the functional difference between growth arrest-specific protein 6 and protein S: an evolutionary approach.

Authors:  Romain A Studer; Fred R Opperdoes; Gerry A F Nicolaes; André B Mulder; René Mulder
Journal:  Open Biol       Date:  2014-10       Impact factor: 6.411

5.  An Acute Abdominal Catastrophe in a HIV Positive Patient.

Authors:  Vinaya Gaduputi; Harish Patel; Vamshidhar Vootla; Usman Khan; Sridhar Chilimuri
Journal:  Gastroenterology Res       Date:  2012-05-20

6.  Clinical Characteristics of HIV-Infected Patients with Venous Thromboembolism and Different CD4+ T Lymphocyte Levels.

Authors:  Yan-Fen Tang; Yu Wang; Tian-Jiao Xue; Gang Liu; Qi Chen; Wen Zhao; Yan-Yan Liu; Rong-Qian Chen; Li Chen; Jing Liu
Journal:  J Inflamm Res       Date:  2022-01-28

Review 7.  Elevated Risk of Venous Thromboembolism in People Living with HIV.

Authors:  Quan Zhang; Fei Peng; Meizhi Li; Qiong Yi; Wei Tang; Shangjie Wu
Journal:  Viruses       Date:  2022-03-12       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.